BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 38541203)

  • 21. Clinicopathological characteristics and treatment outcomes of 38 cases of primary thyroid lymphoma: a multicenter study.
    Chai YJ; Hong JH; Koo do H; Yu HW; Lee JH; Kwon H; Kim SJ; Choi JY; Lee KE
    Ann Surg Treat Res; 2015 Dec; 89(6):295-9. PubMed ID: 26665123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary thyroid T-lymphoblastic lymphoma: a case report and review of the literature.
    Chen C; Yang Y; Jin L; Dong L; Zhang X; Xiang Y
    Int J Clin Exp Pathol; 2014; 7(1):443-50. PubMed ID: 24427370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid lymphoma: recent advances in diagnosis and optimal management strategies.
    Walsh S; Lowery AJ; Evoy D; McDermott EW; Prichard RS
    Oncologist; 2013; 18(9):994-1003. PubMed ID: 23881987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary thyroid lymphoma: a clinical review.
    Stein SA; Wartofsky L
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3131-8. PubMed ID: 23714679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic study and outcome analysis of thyroid lymphomas: experience from a tertiary cancer center.
    Katna R; Shet T; Sengar M; Menon H; Laskar S; Prabhash K; D'Cruz A; Nair R
    Head Neck; 2013 Feb; 35(2):165-71. PubMed ID: 22368156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre.
    Alzouebi M; Goepel JR; Horsman JM; Hancock BW
    Int J Oncol; 2012 Jun; 40(6):2075-80. PubMed ID: 22367111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transformation of follicular lymphoma.
    Lossos IS; Gascoyne RD
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):147-63. PubMed ID: 21658615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24553 patients with Hashimoto's disease.
    Watanabe N; Noh JY; Narimatsu H; Takeuchi K; Yamaguchi T; Kameyama K; Kobayashi K; Kami M; Kubo A; Kunii Y; Shimizu T; Mukasa K; Otsuka F; Miyara A; Minagawa A; Ito K; Ito K
    Br J Haematol; 2011 Apr; 153(2):236-43. PubMed ID: 21371004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study.
    Onal C; Li YX; Miller RC; Poortmans P; Constantinou N; Weber DC; Atasoy BM; Igdem S; Ozsahin M; Ozyar E
    Ann Oncol; 2011 Jan; 22(1):156-164. PubMed ID: 20587509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
    Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
    Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network.
    Klapper W; Hoster E; Determann O; Oschlies I; van der Laak J; Berger F; Bernd HW; Cabeçadas J; Campo E; Cogliatti S; Hansmann ML; Kluin PM; Kodet R; Krivolapov YA; Loddenkemper C; Stein H; Möller P; Barth TE; Müller-Hermelink K; Rosenwald A; Ott G; Pileri S; Ralfkiaer E; Rymkiewicz G; van Krieken JH; Wacker HH; Unterhalt M; Hiddemann W; Dreyling M;
    J Hematop; 2009 Jul; 2(2):103-11. PubMed ID: 19669190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
    Al-Tourah AJ; Gill KK; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Sehn LH; Shenkier TN; Gascoyne RD; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5165-9. PubMed ID: 18838711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update of the epidemiology of non-Hodgkin's lymphoma.
    Chiu BC; Weisenburger DD
    Clin Lymphoma; 2003 Dec; 4(3):161-8. PubMed ID: 14715098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary thyroid lymphoma is a heterogeneous disease.
    Thieblemont C; Mayer A; Dumontet C; Barbier Y; Callet-Bauchu E; Felman P; Berger F; Ducottet X; Martin C; Salles G; Orgiazzi J; Coiffier B
    J Clin Endocrinol Metab; 2002 Jan; 87(1):105-11. PubMed ID: 11788631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hashimoto's disease and thyroid lymphoma: role of the surgeon.
    Pasieka JL
    World J Surg; 2000 Aug; 24(8):966-70. PubMed ID: 10865042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases.
    Derringer GA; Thompson LD; Frommelt RA; Bijwaard KE; Heffess CS; Abbondanzo SL
    Am J Surg Pathol; 2000 May; 24(5):623-39. PubMed ID: 10800981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary non-Hodgkin's lymphoma of the thyroid gland: a population based study.
    Pedersen RK; Pedersen NT
    Histopathology; 1996 Jan; 28(1):25-32. PubMed ID: 8838117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland.
    Kato I; Tajima K; Suchi T; Aozasa K; Matsuzuka F; Kuma K; Tominaga S
    Jpn J Cancer Res; 1985 Nov; 76(11):1085-90. PubMed ID: 3936828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer risks in patients with chronic lymphocytic thyroiditis.
    Holm LE; Blomgren H; Löwhagen T
    N Engl J Med; 1985 Mar; 312(10):601-4. PubMed ID: 3838363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fine-needle aspiration cytology of malignant lymphoma of the thyroid.
    Matsuda M; Sone H; Koyama H; Ishiguro S
    Diagn Cytopathol; 1987 Sep; 3(3):244-9. PubMed ID: 3665692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.